X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (26) 26
hematology (20) 20
middle aged (20) 20
male (19) 19
female (17) 17
adult (16) 16
adolescent (9) 9
aged (9) 9
chronic myeloid leukemia (9) 9
leukemia, myelogenous, chronic, bcr-abl positive - therapy (8) 8
chronic myelogenous leukemia (7) 7
index medicus (7) 7
interferon-alpha - therapeutic use (7) 7
remission induction (7) 7
therapy (7) 7
treatment outcome (7) 7
bone-marrow transplantation (6) 6
survival (6) 6
survival rate (6) 6
antineoplastic combined chemotherapy protocols - therapeutic use (5) 5
fludarabine (5) 5
prognosis (5) 5
risk factors (5) 5
vidarabine - analogs & derivatives (5) 5
acute myelogenous leukemia (4) 4
disease-free survival (4) 4
interferon-alpha (4) 4
karyotyping (4) 4
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (4) 4
oncology (4) 4
recombinant proteins (4) 4
retrospective studies (4) 4
stem cell transplantation (4) 4
time factors (4) 4
vidarabine - administration & dosage (4) 4
acute disease (3) 3
aged, 80 and over (3) 3
antineoplastic agents - adverse effects (3) 3
bacteremia - mortality (3) 3
bone marrow - pathology (3) 3
bone marrow transplantation (3) 3
busulfan (3) 3
chronic lymphocytic-leukemia (3) 3
cml (3) 3
cytarabine - administration & dosage (3) 3
health aspects (3) 3
hemic and lymphatic diseases (3) 3
high-dose cytarabine (3) 3
interferon (3) 3
leukemia, myelogenous, chronic, bcr-abl positive - genetics (3) 3
leukemia, myelogenous, chronic, bcr-abl positive - mortality (3) 3
leukemia, myelogenous, chronic, bcr-abl positive - pathology (3) 3
leukemia, myeloid - drug therapy (3) 3
medicine, general & internal (3) 3
recurrence (3) 3
stem cells (3) 3
young adult (3) 3
acute myeloid leukaemia (2) 2
adhesion (2) 2
alpha-interferon (2) 2
analysis (2) 2
antineoplastic agents - therapeutic use (2) 2
antineoplastic combined chemotherapy protocols - administration & dosage (2) 2
autografts (2) 2
bacteremia (2) 2
base sequence (2) 2
blast crisis (2) 2
bone marrow microenvironment (2) 2
cancer (2) 2
care and treatment (2) 2
chemotherapy (2) 2
chronic myeloid-leukemia (2) 2
chronic phase (2) 2
chronic-phase (2) 2
colony-stimulating factor (2) 2
combined modality therapy (2) 2
cytogenetic responses (2) 2
cytosine-arabinoside (2) 2
double-blind (2) 2
double-blind method (2) 2
efficacy (2) 2
empiric therapy (2) 2
enterobacteriaceae (2) 2
epidemiology (2) 2
etoposide - administration & dosage (2) 2
evaluation (2) 2
expression (2) 2
fever (2) 2
follow-up studies (2) 2
fusion proteins, bcr-abl - genetics (2) 2
g-csf (2) 2
gene-expression (2) 2
hematologic malignancies (2) 2
hematopoietic stem cell mobilization (2) 2
hydroxyurea (2) 2
hydroxyurea - therapeutic use (2) 2
idarubicin (2) 2
idarubicin - administration & dosage (2) 2
ifnα (2) 2
imatinib mesylate (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 09/2005, Volume 353, Issue 10, pp. 977 - 987
Journal Article
Blood, ISSN 0006-4971, 12/2011, Volume 118, Issue 25, pp. 6521 - 6528
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 2014, Volume 32, Issue 14, pp. 1463 - 1471
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 329 - 329
Abstract Background: Older (age ≥60 years) patients with acute myeloid leukemia (AML) have poor outcomes and intensive induction chemotherapy is frequently... 
Journal Article
Haematologica, ISSN 0390-6078, 12/2008, Volume 93, Issue 12, pp. 1792 - 1796
Journal Article
Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia, 01/2017, Volume 34, Issue 1
Journal Article
British Journal of Haematology, ISSN 0007-1048, 10/2005, Volume 131, Issue 2, pp. 172 - 179
Journal Article
Journal Article
Blood, ISSN 0006-4971, 09/1998, Volume 92, Issue 5, pp. 1541 - 1548
Several prospective randomized studies have shown that the treatment of chronic myeloid leukemia with interferon-ru (IFN-alpha) prolongs the survival by... 
CHRONIC MYELOGENOUS LEUKEMIA | SURVIVAL | THERAPY | BONE-MARROW TRANSPLANTATION | CHRONIC-PHASE | CYTOGENETIC IMPROVEMENT | HEMATOLOGY | MINIMAL RESIDUAL DISEASE | BUSULFAN | REMISSION
Journal Article
European Journal of Haematology, ISSN 0902-4441, 11/2008, Volume 81, Issue 5, pp. 354 - 363
Journal Article
British Journal of Haematology, ISSN 0007-1048, 01/2007, Volume 136, Issue 1, pp. 87 - 95
Journal Article
Blood, ISSN 0006-4971, 11/2007, Volume 110, Issue 11, pp. 4351 - 4351
Abstract Infections are the major cause of morbidity and mortality of acute myeloid leukemia (AML). Invasive Fungal Infections (IFIs) occur in at least 10 to... 
Journal Article
Journal Article